Skip to main content
Top
Published in: Annals of Nuclear Medicine 10/2016

01-12-2016 | Original Article

Analysis of the influence of 111In on 90Y-bremsstrahlung SPECT based on Monte Carlo simulation

Authors: Hiroaki Shiba, Akihiko Takahashi, Shingo Baba, Kazuhiko Himuro, Yasuo Yamashita, Masayuki Sasaki

Published in: Annals of Nuclear Medicine | Issue 10/2016

Login to get access

Abstract

Objective

90Y-ibritumomab tiuxetan (Zevalin) which is used for the treatment of malignant lymphomas can be used for SPECT imaging based on bremsstrahlung from 90Y beta particles. However, gamma rays emitted by 111In, which is administered to evaluate the indication for the treatment, contaminate the 90Y bremsstrahlung images. Our objective is to investigate the influence of 111In on the 90Y SPECT images using Monte Carlo simulation.

Methods

We used an in-house developed simulation code for the Monte Carlo simulation of electrons and photons (MCEP). Two hot spheres with diameters of 40 mm were put in an elliptical phantom. Both spheres (“sphere 1” and “sphere 2”) were filled with 90Y and 111In mixed solutions. The activities of 90Y in sphere 1 and sphere 2 were 241 and 394 kBq/mL, respectively, and the ones of 111In were 8.14 and 13.3 kBq/mL, respectively. The background activity of 90Y was 38.6 kBq/mL, whereas that of 111In was 1.30 kBq/mL; moreover, the acquisition time was 30 min. Two energy windows were used: one is 90–190 keV included the 111In photopeak; the other is 90–160 keV. To evaluate the quality of the SPECT images, the contrast recovery coefficient (CRC) and the constant noise ratio (CNR) of the SPECT images were derived.

Results

For the energy window between 90 and 160 keV, the 111In count was 74 % of the total. In that case, the CRC values were 30.1 and 30.7 % for “sphere 1” and “sphere 2”, respectively, whereas the CNR values were 6.8 and 12.1, respectively. For the energy window between 90 and 190 keV, the 111In count reached 85 % of the total count. The CRC and CNR values were 38.6 and 40.0 % and 10.6 and 19.4, respectively.

Conclusions

Our simulation study revealed that the cross talk between 111In and 90Y in SPECT imaging is rather serious. Even for the energy window excluding the 111In photopeak, the count ratio of 90Y was less than 30 % of the total. However, the influence of 111In on 90Y-SPECT imaging cannot be ignored, and the count ratio because of 111In is important to estimate the density of 90Y.
Literature
2.
go back to reference Minarik D, Gleisner KS, Ljungberg M. Evaluation of quantitative 90Y SPECT based on experimental phantom studies. Phys Med Biol. 2008;53:5689–703.CrossRefPubMed Minarik D, Gleisner KS, Ljungberg M. Evaluation of quantitative 90Y SPECT based on experimental phantom studies. Phys Med Biol. 2008;53:5689–703.CrossRefPubMed
3.
go back to reference Ljungberg M, Gleisner KS. The accuracy of absorbed dose estimates in tumors determined by quantitative SPECT: a Monte Carlo study. Acta Oncol. 2011;50:981–9.CrossRefPubMed Ljungberg M, Gleisner KS. The accuracy of absorbed dose estimates in tumors determined by quantitative SPECT: a Monte Carlo study. Acta Oncol. 2011;50:981–9.CrossRefPubMed
4.
go back to reference Rong X, Du Y, Ljungberg M, Rault E, Vandenberghe S, Frey EC. Development and evaluation of an improved quantitative 90Y bremsstrahlung SPECT method. Med Phys. 2012;39:2346–58.CrossRefPubMedPubMedCentral Rong X, Du Y, Ljungberg M, Rault E, Vandenberghe S, Frey EC. Development and evaluation of an improved quantitative 90Y bremsstrahlung SPECT method. Med Phys. 2012;39:2346–58.CrossRefPubMedPubMedCentral
5.
go back to reference Minarik D, Gleisner KS, Ljungberg M. Evaluation of quantitative planer 90Y bremsstrahlung whole-body imaging. Phys Med Biol. 2009;54:5873–83.CrossRefPubMed Minarik D, Gleisner KS, Ljungberg M. Evaluation of quantitative planer 90Y bremsstrahlung whole-body imaging. Phys Med Biol. 2009;54:5873–83.CrossRefPubMed
6.
go back to reference Elschot M, Lam MG, van den Bosch MA, Viergever MA, de Jong HW. Quantitative Monte Carlo-based 90Y SPECT reconstruction. J Nucl Med. 2013;54:1557–63.CrossRefPubMed Elschot M, Lam MG, van den Bosch MA, Viergever MA, de Jong HW. Quantitative Monte Carlo-based 90Y SPECT reconstruction. J Nucl Med. 2013;54:1557–63.CrossRefPubMed
7.
go back to reference Takahashi A, Himuro K, Yamashita Y, Komiya I, Baba S, Sasaki M. Monte Carlo simulation of PET and SPECT imaging of 90Y. Med Phys. 2015;42:1926–35.CrossRefPubMed Takahashi A, Himuro K, Yamashita Y, Komiya I, Baba S, Sasaki M. Monte Carlo simulation of PET and SPECT imaging of 90Y. Med Phys. 2015;42:1926–35.CrossRefPubMed
8.
go back to reference Tanaka M, Uehara S, Kojima A, Matsumoto M. Monte Carlo simulation of energy spectra for 123I imaging. Phys Med Biol. 2007;52:4409–25.CrossRefPubMed Tanaka M, Uehara S, Kojima A, Matsumoto M. Monte Carlo simulation of energy spectra for 123I imaging. Phys Med Biol. 2007;52:4409–25.CrossRefPubMed
9.
go back to reference Moore SC, Park MA, Cervo M, Miiller SP. A fast Monte Carlo-based forward projector with complete physics modeling of Y-90 bremsstrahlung. In: IEEE nuclear science symposium and medical imaging conference record (NSS/MIC); 2012. pp. 2699–701. doi:10.1109/NSSMIC.2012.6551614. Moore SC, Park MA, Cervo M, Miiller SP. A fast Monte Carlo-based forward projector with complete physics modeling of Y-90 bremsstrahlung. In: IEEE nuclear science symposium and medical imaging conference record (NSS/MIC); 2012. pp. 2699–701. doi:10.​1109/​NSSMIC.​2012.​6551614.
10.
go back to reference Wiseman GA, White CA, Stabin M, Dunn WL, Erwin W, Dahlbom M, et al. Phase I/II 90Y-Zevalin (yttrium-90 ibritumomab tiuxetan, IDEC-Y2B8) radioimmunotherapy dosimetry results in relapsed or refractory non-Hodgkin’s lymphoma. Eur J Nucl Med. 2000;27:766–77.CrossRefPubMed Wiseman GA, White CA, Stabin M, Dunn WL, Erwin W, Dahlbom M, et al. Phase I/II 90Y-Zevalin (yttrium-90 ibritumomab tiuxetan, IDEC-Y2B8) radioimmunotherapy dosimetry results in relapsed or refractory non-Hodgkin’s lymphoma. Eur J Nucl Med. 2000;27:766–77.CrossRefPubMed
11.
go back to reference Minarik D, Gleisner KS, Linden O, Wingårdh K, Tennvall J, Strand S-E, et al. 90Y bremsstrahlung imaging for absorbed-dose assessment in high-dose radioimmunotherapy. J Nucl Med. 2010;51:1974–8.CrossRefPubMed Minarik D, Gleisner KS, Linden O, Wingårdh K, Tennvall J, Strand S-E, et al. 90Y bremsstrahlung imaging for absorbed-dose assessment in high-dose radioimmunotherapy. J Nucl Med. 2010;51:1974–8.CrossRefPubMed
12.
go back to reference Darrell RF, Sui S, Ruby FM. MIRD dose estimate report No. 20: radiation absorbed-dose estimates for 111In- and 90Y-ibritumomab tiuxetan. J Nucl Med. 2009;50:644–52. Darrell RF, Sui S, Ruby FM. MIRD dose estimate report No. 20: radiation absorbed-dose estimates for 111In- and 90Y-ibritumomab tiuxetan. J Nucl Med. 2009;50:644–52.
14.
go back to reference Rhymer SM, Parker JA, Palmer MR. Detection of 90Y extravasation by bremsstrahlung imaging for patients undergoing 90Y-ibritumomab tiuxetan therapy. J Nucl Med. 2010;38:195–8.CrossRef Rhymer SM, Parker JA, Palmer MR. Detection of 90Y extravasation by bremsstrahlung imaging for patients undergoing 90Y-ibritumomab tiuxetan therapy. J Nucl Med. 2010;38:195–8.CrossRef
15.
go back to reference Walrand S, Hesse M, Demonceau G, Pauwels S, Jamar F. Yttrium-90-labeled microsphere tracking during liver selective internal radiotherapy by bremsstrahlung pinhole SPECT: feasibility study and evaluation in an abdominal phantom. EJNMMI Res. 2011;1:1–14.CrossRef Walrand S, Hesse M, Demonceau G, Pauwels S, Jamar F. Yttrium-90-labeled microsphere tracking during liver selective internal radiotherapy by bremsstrahlung pinhole SPECT: feasibility study and evaluation in an abdominal phantom. EJNMMI Res. 2011;1:1–14.CrossRef
16.
go back to reference Carlier T, Eugène T, Bodet-Milin C, Garin E, Ansquer C, Rousseau C, et al. Assessment of acquisition protocols for routine imaging of Y-90 using PET/CT. EJNMMI Res. 2013;3:11.CrossRefPubMedPubMedCentral Carlier T, Eugène T, Bodet-Milin C, Garin E, Ansquer C, Rousseau C, et al. Assessment of acquisition protocols for routine imaging of Y-90 using PET/CT. EJNMMI Res. 2013;3:11.CrossRefPubMedPubMedCentral
17.
go back to reference Tapp KN, Lea WB, Johnson MS, Tann M, Fletcher JW, Hutchins GD. The impact of image reconstruction bias on PET/CT 90Y dosimetry after radioembolization. J Nucl Med. 2014;55:1452–8.CrossRefPubMed Tapp KN, Lea WB, Johnson MS, Tann M, Fletcher JW, Hutchins GD. The impact of image reconstruction bias on PET/CT 90Y dosimetry after radioembolization. J Nucl Med. 2014;55:1452–8.CrossRefPubMed
18.
go back to reference Cherry SR, Sorenson JA, Phelps ME. Physics in nuclear medicine. 3rd ed. Philadelphia: Saunders; 2003. p. 264–70. Cherry SR, Sorenson JA, Phelps ME. Physics in nuclear medicine. 3rd ed. Philadelphia: Saunders; 2003. p. 264–70.
Metadata
Title
Analysis of the influence of 111In on 90Y-bremsstrahlung SPECT based on Monte Carlo simulation
Authors
Hiroaki Shiba
Akihiko Takahashi
Shingo Baba
Kazuhiko Himuro
Yasuo Yamashita
Masayuki Sasaki
Publication date
01-12-2016
Publisher
Springer Japan
Published in
Annals of Nuclear Medicine / Issue 10/2016
Print ISSN: 0914-7187
Electronic ISSN: 1864-6433
DOI
https://doi.org/10.1007/s12149-016-1112-9

Other articles of this Issue 10/2016

Annals of Nuclear Medicine 10/2016 Go to the issue